Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Quality Index
Shenzhen Hepalink Pharmaceutical Co Ltd cash flow quality index. Shenzhen Hepalink Pharmaceutical Co Ltd (002399) has a Cash Flow Quality Index of 3.03x as of September 2025. Operating cash flow of CN¥399.43 Million exceeds net income of CN¥131.73 Million, indicating high earnings quality where cash backs reported profits. See 002399 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shenzhen Hepalink Pharmaceutical Co Ltd (2007–2025)
Cash flow quality index of Shenzhen Hepalink Pharmaceutical Co Ltd from 2007 to 2025. Historical Cash Flow Quality Index for Shenzhen Hepalink Pharmaceutical Co Ltd across 18 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore 002399 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Shenzhen Hepalink Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2007–2025)
Shenzhen Hepalink Pharmaceutical Co Ltd cash flow quality index by year from 2007 to 2025. Year-by-year earnings quality comparison for Shenzhen Hepalink Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002399 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.90x | CN¥1.71 Billion | CN¥349.49 Million | ▲ +39.6% |
| 2024 | 3.51x | CN¥2.19 Billion | CN¥624.92 Million | ▲ +431.7% |
| 2022 | -1.06x | CN¥-756.61 Million | CN¥714.69 Million | ▼ -3627.0% |
| 2021 | -0.03x | CN¥-6.63 Million | CN¥233.38 Million | ▼ -177.8% |
| 2020 | 0.04x | CN¥37.28 Million | CN¥1.02 Billion | ▲ +116.7% |
| 2019 | -0.22x | CN¥-227.60 Million | CN¥1.04 Billion | ▼ -119.3% |
| 2018 | 1.13x | CN¥667.87 Million | CN¥592.18 Million | ▲ +132.7% |
| 2017 | -3.44x | CN¥-407.12 Million | CN¥118.19 Million | ▼ -484.3% |
| 2016 | 0.90x | CN¥346.07 Million | CN¥386.12 Million | ▼ -43.0% |
| 2015 | 1.57x | CN¥893.71 Million | CN¥568.08 Million | ▼ -42.2% |
| 2014 | 2.72x | CN¥912.80 Million | CN¥335.33 Million | ▲ +102.7% |
| 2013 | 1.34x | CN¥420.97 Million | CN¥313.42 Million | ▲ +74.7% |
| 2012 | 0.77x | CN¥473.89 Million | CN¥616.55 Million | ▼ -66.1% |
| 2011 | 2.27x | CN¥1.41 Billion | CN¥618.94 Million | ▲ +673.4% |
| 2010 | 0.29x | CN¥354.86 Million | CN¥1.21 Billion | ▼ -33.2% |
| 2009 | 0.44x | CN¥355.81 Million | CN¥809.06 Million | ▲ +76.9% |
| 2008 | 0.25x | CN¥40.13 Million | CN¥161.39 Million | ▲ +22.4% |
| 2007 | 0.20x | CN¥13.85 Million | CN¥68.16 Million | — |